BE1002063A4 - Association medicamenteuse a base d'un inhibiteur calcique. - Google Patents
Association medicamenteuse a base d'un inhibiteur calcique. Download PDFInfo
- Publication number
- BE1002063A4 BE1002063A4 BE8701236A BE8701236A BE1002063A4 BE 1002063 A4 BE1002063 A4 BE 1002063A4 BE 8701236 A BE8701236 A BE 8701236A BE 8701236 A BE8701236 A BE 8701236A BE 1002063 A4 BE1002063 A4 BE 1002063A4
- Authority
- BE
- Belgium
- Prior art keywords
- association based
- drug association
- calcium inhibitor
- calcium
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868626217A GB8626217D0 (en) | 1986-11-03 | 1986-11-03 | Pharmaceutical compositions |
GB878713349A GB8713349D0 (en) | 1987-06-08 | 1987-06-08 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BE1002063A4 true BE1002063A4 (fr) | 1990-06-12 |
Family
ID=26291485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE8701236A BE1002063A4 (fr) | 1986-11-03 | 1987-10-30 | Association medicamenteuse a base d'un inhibiteur calcique. |
Country Status (25)
Country | Link |
---|---|
KR (1) | KR960005145B1 (nl) |
AT (1) | AT397343B (nl) |
AU (1) | AU615883B2 (nl) |
BE (1) | BE1002063A4 (nl) |
CA (1) | CA1314222C (nl) |
CH (1) | CH677189A5 (nl) |
DE (1) | DE3736505A1 (nl) |
DK (1) | DK574087A (nl) |
ES (1) | ES2010524A6 (nl) |
FI (1) | FI874823A (nl) |
FR (1) | FR2605885B1 (nl) |
GR (1) | GR871680B (nl) |
HK (1) | HK138893A (nl) |
HU (1) | HU199681B (nl) |
IE (1) | IE60496B1 (nl) |
IL (1) | IL84343A (nl) |
IT (1) | IT1212037B (nl) |
LU (1) | LU87034A1 (nl) |
MY (1) | MY102124A (nl) |
NL (1) | NL8702502A (nl) |
NO (1) | NO874539L (nl) |
NZ (1) | NZ222401A (nl) |
PH (1) | PH23249A (nl) |
PT (1) | PT86062B (nl) |
SE (1) | SE8704272L (nl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3818245A1 (de) * | 1988-05-28 | 1989-12-07 | Hoechst Ag | Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln |
FR2733911B1 (fr) * | 1995-05-09 | 1998-05-29 | Takeda Chemical Industries Ltd | Composition pharmaceutique pour maladies renales ou cardio-vasculaires |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4470972A (en) * | 1981-04-28 | 1984-09-11 | Schering Corporation | 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids |
EP0180785A1 (de) * | 1984-10-17 | 1986-05-14 | Bayer Ag | Arzneimittel, enthaltend eine Kombination von Nitrendipin mit Enalapril, und Verfahren zu seiner Herstellung |
EP0265685A2 (de) * | 1986-10-02 | 1988-05-04 | Hoechst Aktiengesellschaft | Kombination von Angiotensin- Converting-Enzyme-Hemmern mit Calciumantagonisten sowie deren Verwendung in Arzneimitteln |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4520021A (en) * | 1982-07-02 | 1985-05-28 | Merck & Co., Inc. | Substituted caprolactam derivatives as antihypertensives |
GB2198641B (en) * | 1986-11-03 | 1990-09-19 | Sandoz Ltd | Pharmaceutical composition for use against hypertension and congestive heart failure |
IL88502A (en) * | 1987-12-14 | 1993-04-04 | Squibb & Sons Inc | Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor |
-
1987
- 1987-10-20 NL NL8702502A patent/NL8702502A/nl not_active Application Discontinuation
- 1987-10-20 HU HU874712A patent/HU199681B/hu not_active IP Right Cessation
- 1987-10-28 CH CH4224/87A patent/CH677189A5/de not_active IP Right Cessation
- 1987-10-28 DE DE19873736505 patent/DE3736505A1/de not_active Ceased
- 1987-10-30 CA CA000551575A patent/CA1314222C/en not_active Expired - Fee Related
- 1987-10-30 IT IT8748553A patent/IT1212037B/it active
- 1987-10-30 LU LU87034A patent/LU87034A1/fr unknown
- 1987-10-30 BE BE8701236A patent/BE1002063A4/fr not_active IP Right Cessation
- 1987-10-30 FR FR8715186A patent/FR2605885B1/fr not_active Expired - Fee Related
- 1987-11-02 SE SE8704272A patent/SE8704272L/xx unknown
- 1987-11-02 MY MYPI87003005A patent/MY102124A/en unknown
- 1987-11-02 NZ NZ222401A patent/NZ222401A/en unknown
- 1987-11-02 AT AT0286987A patent/AT397343B/de not_active IP Right Cessation
- 1987-11-02 AU AU80576/87A patent/AU615883B2/en not_active Ceased
- 1987-11-02 PT PT86062A patent/PT86062B/pt not_active IP Right Cessation
- 1987-11-02 DK DK574087A patent/DK574087A/da not_active Application Discontinuation
- 1987-11-02 FI FI874823A patent/FI874823A/fi not_active Application Discontinuation
- 1987-11-02 IL IL84343A patent/IL84343A/xx unknown
- 1987-11-02 IE IE295187A patent/IE60496B1/en not_active IP Right Cessation
- 1987-11-02 GR GR871680A patent/GR871680B/el unknown
- 1987-11-02 KR KR1019870012319A patent/KR960005145B1/ko active IP Right Grant
- 1987-11-02 NO NO874539A patent/NO874539L/no unknown
- 1987-11-03 PH PH36019A patent/PH23249A/en unknown
- 1987-11-03 ES ES8703141A patent/ES2010524A6/es not_active Expired
-
1993
- 1993-12-16 HK HK1388/93A patent/HK138893A/xx not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4470972A (en) * | 1981-04-28 | 1984-09-11 | Schering Corporation | 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids |
EP0180785A1 (de) * | 1984-10-17 | 1986-05-14 | Bayer Ag | Arzneimittel, enthaltend eine Kombination von Nitrendipin mit Enalapril, und Verfahren zu seiner Herstellung |
EP0265685A2 (de) * | 1986-10-02 | 1988-05-04 | Hoechst Aktiengesellschaft | Kombination von Angiotensin- Converting-Enzyme-Hemmern mit Calciumantagonisten sowie deren Verwendung in Arzneimitteln |
Non-Patent Citations (1)
Title |
---|
LA REVUE DE MEDICINE INTERNE, vol. 7, no. 4, 1986, pages 433-440; A. SIMON: "Hypertension artérielle essentielle: stratégie d'emploi des médicaments antihypertenseurs" * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA08617A (fr) | Inhibiteurs de métalloendopeptidase neutre dans le traitement de l'hypertention. | |
DE59905954D1 (de) | Dialkylfumarate zur behandlung von autoimmunerkrankungen | |
ATE49126T1 (de) | Mittel zur transdermalen applikation von arzneistoffen. | |
ATE230757T1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
MX163955B (es) | Composicion farmaceutica de dihidrocodeina e ibuprofen | |
DE68923819T2 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
IT8621358A0 (it) | Composizione farmaceutica adattivita' analgesica. | |
SE9103332D0 (sv) | Method for the diagnosis of blood coagulation desorders | |
ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
DE68907679T2 (de) | Sauerwiderstehender Fibroblast-Wachstumsfaktor, Zubereitung zur Behandlung von Magen-Darmweg-Geschwürkrankheiten. | |
ATE181422T1 (de) | Verfahren zur diagnose von praeklampsie | |
ATE54824T1 (de) | System zur arzneistoffabgabe mit erhoehter bioakzeptanz. | |
DE69201660T2 (de) | Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma. | |
DE3875867D1 (de) | Kalziumzusaetze. | |
DE3781488D1 (de) | Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten. | |
BE1002504A3 (fr) | Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. | |
BE1002063A4 (fr) | Association medicamenteuse a base d'un inhibiteur calcique. | |
DE3867086D1 (de) | Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen. | |
HUP9900227A2 (hu) | AII-receptor antagonisták új gyógyszerészeti felhasználása | |
ATE67410T1 (de) | Methode zur behandlung der antidiurese. | |
ATE42308T1 (de) | Pharmakologisch aktive peptide. | |
FR2412313A1 (fr) | Composition pharmaceutique a base de mono-saccharide et d'amino-acide administrable par voie orale a des etres humains | |
BE899434A (fr) | Nouvelle association medicamenteuse pour le traitement de l'hypertension. | |
DE3782594T2 (de) | Arzneimittel zur transdermalen verabreichung von nicorandil. | |
ATE126437T1 (de) | Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: *NOVARTIS A.G. Effective date: 20021031 |